Predictors of Progression of Coronary Atherosclerosis after Percutaneous Coronary Intervention

1. Bønaa K, Mannsverk J, Wiseth R, et al. - Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med. 2016;375:1242-1252.10.1056/NEJMoa1607991Search in Google Scholar

2. Kaneko H, Yajima J, Oikawa Y, et al. - Long-term incidence and prognostic factors of progression of new coronary lesions in Japanese coronary artery disease patients after percutaneous coronary intervention. Heart Vessels. 2014;29:437-442.10.1007/s00380-013-0382-6Search in Google Scholar

3. Park MW, Seung KB, Kim PJ, et al. - Long-term percutaneous coronary intervention rates and associated independent predictors for progression of nonintervened nonculprit coronary lesions. Am J Cardiol. 2009;104:648-652.10.1016/j.amjcard.2009.04.052Search in Google Scholar

4. Sipahi I, Tuzcu EM, Schoenhagen P, et al. - Effects of normal, prehypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol. 2006;48:833-838.10.1016/j.jacc.2006.05.045Search in Google Scholar

5. Borges JC, Lopes N, Soares PR, et al. - Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery. J Cardiothorac Surg. 2010;5:91.10.1186/1749-8090-5-91Search in Google Scholar

6. Boden WE, O’Rourke RA, Teo KK, et al. - Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516.10.1056/NEJMoa070829Search in Google Scholar

7. Ellis SG, Stone GW, Cox DA, et al. - Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: treatment of de novo coronary disease using a single paclitaxel-eluting stent). JACC Cardiovasc Interv. 2009;2:1248-1259.10.1016/j.jcin.2009.10.003Search in Google Scholar

8. Bangalore S, Kumar S, Fusaro M, et al. - Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixedtreatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012;125:2873-2891.10.1161/CIRCULATIONAHA.112.097014Search in Google Scholar

9. Zellweger MJ, Kaiser C, Jeger R, et al. - Coronary artery disease progression late after successful stent implantation. J Am Coll Cardiol. 2012;59:793-799.10.1016/j.jacc.2011.11.024Search in Google Scholar

10. Alderman EL, Corley SD, Fisher LD, et al. - Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the coronary artery surgery study (CASS). CASS participating investigators and staff. J Am Coll Cardiol. 1993;22:1141-1154.10.1016/0735-1097(93)90429-5Search in Google Scholar

11. Lichtlen PR, Nikutta P, Jost S, et al. - Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitative coronary angiography. Relation to clinical events and risk factors. The INTACT Study Group. Circulation. 1992;86:828-838.10.1161/01.CIR.86.3.828Search in Google Scholar

12. Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable Artery disease Investigators - Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782-788.10.1016/S0140-6736(03)14286-9Search in Google Scholar

13. Gude D - Angiotensin-converting enzyme inhibitors in lipid metabolism and atherosclerosis: An ace up the sleeve? J Sci Soc. 2014;41;59-60.10.4103/0974-5009.126762Search in Google Scholar